Cargando…
A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
Pancreatic adenocarcinoma (PAAD) is a major threat to people's health. PRDM1 is a transcription factor with multiple functions, and its functions have been validated in a variety of tumors; however, there are few studies reported on PRDM1 in PAAD. Using the GEPIA2 database, this research found...
Autores principales: | Zhou, Bo, Zhang, Jie, Zhu, Hongda, Wu, Shugeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123419/ https://www.ncbi.nlm.nih.gov/pubmed/35607327 http://dx.doi.org/10.1155/2022/1934381 |
Ejemplares similares
-
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022) -
PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer
por: Moriya, Chiharu, et al.
Publicado: (2018) -
PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response
por: Ye, Jie, et al.
Publicado: (2020) -
PRDM16 functions as a suppressor of lung adenocarcinoma metastasis
por: Fei, Liang-Ru, et al.
Publicado: (2019) -
AKT1, PRDM4, and BAX are the natural markers of psychological endurance threshold
por: Xu, Zhijian, et al.
Publicado: (2019)